Commitment to Excellence

LB RESEARCH INVESTS 12% OF ITS TURNOVER IN:


QUALITY


PERSONNEL TRAINING


RESEARCH & TECHNOLOGY INNOVATION

Skills in Clinical Trials

LB HAS BEEN COLLABORATING WITH MANY LOCAL AND INTERNATIONAL PHARMACEUTICAL COMPANIES IN THE MANAGEMENT OF THE FOLLOWING STUDIES

Therapeutic areas expertise

CARDIOVASCULAR

  • Acute Coronary Syndrome
  • Hypertension
  • Heart Failure
  • Lower Limbs Arteriopathy

RHEUMATOLOGY

  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Scapular-Humeral, Rheumatism
  • Fibromyalgia
  • Ostheoarthritis

DIABETOLOGY / ENDOCRINOLOGY

  • Diabetes Type I
  • Diabetes Type II
  • Metabolic Syndrome
  • Hypothiroidism
  • Hyperthiroidism

GASTROENTEROLOGY

  • GERD
  • NERD
  • Gastritis
  • Duodenal Ulcer
  • IBS
  • Ulcerative Colitis
  • Crohn’s Disease
  • Diverticulitis

PNEUMOLOGY

  • BPCO
  • Asthma
  • CROUP
  • Enphysema

ORL

  • Chronic and Acute Rhinitis
  • Sinusitis

URO-ANDROLOGY / GYNECOLOGY

  • Urinary Incontinence
  • Benign Prostatic Hypertrophy
  • Cystitis
  • Erectile Dysfunction
  • Testosterone Deficiency
  • In Vitro Fertilization

PAIN

  • Cancer Pain
  • Neuropathic Pain
  • Post-Surgery Pain
  • Preemptive Analgesia
  • Algodystrophy
  • Acute soft tissue trauma
  • Acute low back pain

HAEMATOLOGY

  • Haemophilia type A
  • Thalassemia
  • Anemia

NEUROLOGY / PSYCHIATRY

  • Bipolar Disorders
  • Schizophrenia
  • Parkinson’s Disease
  • Alzheimer’s Disease
  • Epilepsy in Children
  • Amyotrophic Lateral Sclerosis

DERMATOLOGY

  • Psoriasis
  • VZV
  • HSV
  • Chronic Venous Ulcers

ORTHOPEDICS

  • Epicondylitis
  • Hip Arthrosis
  • Shoulder Arthrosis
  • Knee Arthrosis
  • Tendinitis

IMMUNOLOGY

  • Celiac disease
  • SLE
  • Angioedema
  • Myasthenia

VIROLOGY

  • HCV
  • HBV
  • HIV
  • Clostridium Difficile

VACCINES

  • Epatitis B
  • Influenza
  • HIV

Oncology expertise

Trials with General Practitioners Experiences

MORE THAN
350
GPs

MORE THAN
10.500
PATIENTS

Trials with General Practitioners Experiences

MORE THAN
350
GPs

MORE THAN
10.500
PATIENTS

Activities and Services

PRE-STUDY ACTIVITIES

  • Trial Planning and Organization
  • Sites Selection
  • Investigators Selection
  • Feasibility Study
  • Synopsis and Protocol Development
  • CRF Design

CLINICAL TRIAL START-UP

  • Preparation of “Single Opinion”
  • Submission to local ECs
  • Contracts with sites
  • Update of OssSC

MONITORING

  • Pre-study visits
  • Study Initiation visits
  • Routine Monitoring visits
  • Remote Electronic Monitoring (REM)
  • Close-out visits

PROJECT MANAGEMENT

  • Sites Coordination
  • Monitors Coordination
  • Proposal of Corrective Actions
  • Check of Study progress
  • Updates to Sponsor

DATA MANAGEMENT

  • Data Base Development
  • Data Entry
  • Data Cleaning
  • Queries Resolution
  • AEs and CMs Coding

MEETING ORGANISATION

  • Monitors’Meetings
  • Investigators’Meetings

OTHER SERVICES

  • E-CRF LB “Evidence” (Actide System)
  • Statistics
  • Medical Writing
  • Medical Monitoring
  • Pharmacovigilance
  • Pharmacoeconomic Analysis
  • Central LAB management
  • Drug Supply and Packaging

Meeting Sponsored by LB Research

2016

NUTRITION IN MEDICINE

“Aspetti nutrizionali in medicina”
Speakers: H.Cena, MD (Università PV), ML Fonte, MD (Università PV), C. Oggioni, MD (Università PV)

2015

EPATOLOGY

“Malattie Epatiche: presente e futuro”
Speakers: M. Podda, MD (Istituto Humanitas, MI), M. Zuin, MD (Università MI), P. Invernizzi, MD (Istituto Humanitas, MI)

2014

INFECTIOUS DISEASES

“Malattie Infettive emergenti e riemergenti AIDS, Epatite Cronica, Ebola”
Speakers: G. Rizzardini, MD (Hospital Sacco, MI), M. Clerici, MD (Università MI), C. F. Perno, MD (Università Tor Vergata ROMA)

2011

Cardiology

“L’Ipertensione arteriosa: quali novità per un vecchio problema”
Speakers: M. L. Muiesan, MD (Università BS), G. Lanza, MD (Università VA), A. Zaninelli, MD (Università FI)

2010

Diabetology

“Il diabete, una patologia in continuo aumento”
Speakers: N. Musacchio, MD (HSG), P. Piatti, MD (HSR), S. Genovese, MD (Multimedica)

2009

Oncology

“Terapia antitumorale dalle origini ad oggi e il rapporto tra l’Oncologo ed il Medico di Medicina Generale nel governo del paziente oncologico”
Speakers: N. Zilembo, MD (INT MI), S. Fais, MD (Istituto Superiore Sanità)

Why should you work with LB?

Founders experience (25 years average)

Staff experience (13 years average)

Personnel turnover: 0

Expertise in many therapeutic areas

Global management of the project

Recommended by many big pharmaceutical companies

Respect for timelines

Availability, Flexibility and Confidentiality

High Quality of services

Excellent Quality / Price ratio